REDUCENCT07798128
Evaluation of Catheter Utilization in Female Patients Using Indwelling Urinary Catheters and the PureWick™ Flex Female External Catheter
StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary endpoint(s) modified.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary endpoint(s) modified
- Study title shortened, about 12 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Indwelling Urinary Catheter Utilization Rate Measured as Catheter-Days per Patient-Days
Timeframe: From enrollment (informed consent) until hospital discharge or up to 40 days, whichever occurs first
Secondary (2)
Occurrence of Adverse Events (AEs)
Length of Hospital Stay (LOS)
Arms and interventions
Standard of Care (Indwelling Urinary Catheter)
Participants managed for urinary incontinence using indwelling urinary catheters only, in accordance with routine clinical practice.
PureWick™ Flex Female External Catheter (FFEC) Implementation
Participants managed for urinary incontinence following the introduction of the PureWick™ Female External Catheter, using either the external catheter alone or in combination with indwelling urinary catheters, in accordance with routine clinical practice.
Devices: PureWick™ Flex Female External Catheter (FFEC), Indwelling Urinary Catheter (IUC)